BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 2377807)

  • 1. [Monoclonal gammopathy of uncertain significance in rheumatic disease].
    Broggini M; Cavallo A; Baratelli E; Volonté S; Crespi E; Cappelli A; Chelazzi G
    Recenti Prog Med; 1990 May; 81(5):306-9. PubMed ID: 2377807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coexistence of ra, sle, Sjögren's syndrome and monoclonal gammopathy in the same patient.
    Pennec Y; Missoum A; Youinou P; Le Goff P; Le Menn G
    J Rheumatol; 1982; 9(2):334-5. PubMed ID: 7097700
    [No Abstract]   [Full Text] [Related]  

  • 5. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sjogren's syndrome as an overlapping syndrome].
    Asakawa H
    Nihon Rinsho; 1976 Jun; 34(6):1141-6. PubMed ID: 787579
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
    Bencze G
    Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiopulmonary involvement in rheumatic diseases].
    Martínez Lavín M
    Arch Inst Cardiol Mex; 1983; 53(3):247-51. PubMed ID: 6625756
    [No Abstract]   [Full Text] [Related]  

  • 12. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic diseases and the alimentary tract.
    Hawkins C
    Practitioner; 1978 Jan; 220(1315):59-65. PubMed ID: 75543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
    Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
    Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
    Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
    J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease.
    Fauchais AL; Martel C; Gondran G; Lambert M; Launay D; Jauberteau MO; Hachulla E; Vidal E; Hatron PY
    Autoimmun Rev; 2010 Jul; 9(9):595-9. PubMed ID: 20457283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sexual function in rheumatic diseases].
    Araujo DB; Borba EF; Abdo CH; Souza Lde A; Goldenstein-Schainberg C; Chahade WH; Silva CA
    Acta Reumatol Port; 2010; 35(1):16-23. PubMed ID: 20505626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.